Cleared Traditional

K032067 - MAMMOSITE RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER ACCESSORIES TRAY

K032067 is an FDA 510(k) clearance for MAMMOSITE RADIATION THERAPY SYSTEM (RTS..., manufactured by Proxima Therapeutics, Inc.. The device is a Class 2 Radiology device with product code JAQ cleared through the Traditional 510(k) pathway after a 222-day FDA review.

K032067 · Proxima Therapeutics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2004
Decision
222d
Days
Class 2
Risk

K032067 is an FDA 510(k) clearance for the MAMMOSITE RADIATION THERAPY SYSTEM (RTS) TRAY, MAMMOSITE HDR AFTERLOADER ACC.... Classified as System, Applicator, Radionuclide, Remote-controlled (product code JAQ), Class II - Special Controls.

Submitted by Proxima Therapeutics, Inc. (Alpharetta, US). The FDA issued a Cleared decision on February 10, 2004 after a review of 222 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5700 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Proxima Therapeutics, Inc. devices

FDA 510(k) Submission Details - K032067

510(k) Number K032067 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2003
Decision Date February 10, 2004
Days to Decision 222 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 107d · This submission: 222d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAQ Device Classification - Class 2, Special Controls

Product Code JAQ System, Applicator, Radionuclide, Remote-controlled
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAQ System, Applicator, Radionuclide, Remote-controlled

All 143
Devices cleared under the same product code (JAQ) and FDA review panel - the closest regulatory comparables to K032067.
MICROSELECTRON PDR
K041933 · Nucletron Corp. · Aug 2004
MODIFICATION TO HENSCHKE HDR CERVIX APPLICATOR AND HILARIS/NORI HDR CERVIX APPLICATOR
K040704 · Mick Radio-Nuclear Instruments, Inc. · Jun 2004
MAMMOSOURCE HIGH DOSE RATE (HDR) REMOTE AFTERLOADER
K040541 · Varian Medical Systems, Inc. · Mar 2004
CT COMPATIBLE INTRAUTERINE SLEEVES, CAT #0311, 9406
K033828 · Mick Radio-Nuclear Instruments, Inc. · Feb 2004
VARIAN INTRACAVITARY BRACHYTHERAPY APPLICATORS
K033371 · Varian Medical Systems · Dec 2003
GAMMAMED PLUS 3/24 HDR REMOTE AFTERLOADER
K031524 · Varian Medical Systems, Inc. · Nov 2003